Get started
Author

Paul Jurasz

Nanoparticle‐induced platelet aggregation and vascular thrombosis
2005 · Anna Radomski, Paul Jurasz, et al. · British Journal of Pharmacology · 636
PDF
Platelet–cancer interactions: mechanisms and pharmacology of tumour cell‐induced platelet aggregation
2004 · Paul Jurasz, David Alonso‐Escolano, et al. · British Journal of Pharmacology · 358
PDF
The role of platelets in the tumor microenvironment: From solid tumors to leukemia
2015 · MengJie Yan, Paul Jurasz · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 195
Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder
2004 · Wendy E Chrapko, Paul Jurasz, et al. · Biological Psychiatry · 194
Role of metalloproteinases in platelet function
2007 · María José Santos-Martínez, Carlos Medina, et al. · Thrombosis Research · 130
Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide.
2001 · P Jurasz, G Sawicki, et al. · PubMed · 129
Role of apoptosis in pulmonary hypertension: From experimental models to clinical trials
2010 · Paul Jurasz, David Courtman, et al. · Pharmacology & Therapeutics · 124
Alteration of Decreased Plasma NO Metabolites and Platelet NO Synthase Activity by Paroxetine in Depressed Patients
2005 · Wendy Chrapko, Paul Jurasz, et al. · Neuropsychopharmacology · 99
Identification, regulation and role of tissue inhibitor of metalloproteinases‐4 (TIMP‐4) in human platelets
2002 · Anna Radomski, Paul Jurasz, et al. · British Journal of Pharmacology · 82
PDF
Platelet Aggregation-Induced by Caco-2 Cells: Regulation by Matrix Metalloproteinase-2 and Adenosine Diphosphate
2006 · Carlos Medina, Paul Jurasz, et al. · Journal of Pharmacology and Experimental Therapeutics · 81
Mechanisms of action of proteinase‐activated receptor agonists on human platelets
2002 · Ada W Y Chung, Paul Jurasz, et al. · British Journal of Pharmacology · 75
PDF
Hypoxia Results in Upregulation and De Novo Activation of Von Willebrand Factor Expression in Lung Endothelial Cells
2013 · Anahita Mojiri, Maryam Nakhaii-Nejad, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 70
Differential eNOS-signalling by platelet subpopulations regulates adhesion and aggregation
2017 · Aneta Radziwon-Balicka, Gabriela Lesyk, et al. · Cardiovascular Research · 67
Generation and role of angiostatin in human platelets
2003 · Paul Jurasz, David Alonso, et al. · Blood · 66
Functional assessment of von Willebrand factor expression by cancer cells of non-endothelial origin
2016 · Anahita Mojiri, Konstantin Stoletov, et al. · Oncotarget · 58
PDF
Ceramide promotes apoptosis in chronic myelogenous leukemia-derived K562 cells by a mechanism involving caspase-8 and JNK
2008 · Alina Felicia Nica, Chun Chui Tsao, et al. · Cell Cycle · 58
PDF
Platelet–leukocyte aggregation induced by PAR agonists: regulation by nitric oxide and matrix metalloproteinases
2004 · Ada W Y Chung, Anna Radomski, et al. · British Journal of Pharmacology · 55
PDF
Nonremodeling Properties of Matrix Metalloproteinases
2002 · Paul Jurasz, Ada W.Y. Chung, et al. · Circulation Research · 55
CYP1B1 inhibition attenuates doxorubicin-induced cardiotoxicity through a mid-chain HETEs-dependent mechanism
2016 · Zaid H. Maayah, Hassan N. Althurwi, et al. · Pharmacological Research · 53
Protein Kinase Cδ Mediates Platelet-Induced Breast Cancer Cell Invasion
2006 · David Alonso-Escolano, Carlos Medina, et al. · Journal of Pharmacology and Experimental Therapeutics · 49
Platelet-associated angiogenesis regulating factors: a pharmacological perspective
2012 · Aneta Radziwon-Balicka, Cesar Moncada de la Rosa, et al. · Canadian Journal of Physiology and Pharmacology · 47
Generation of platelet angiostatin mediated by urokinase plasminogen activator: effects on angiogenesis
2006 · P. JURASZ, M.J. SANTOS MARTINEZ, et al. · Journal of Thrombosis and Haemostasis · 47
PDF
Advances in Platelet Subpopulation Research
2019 · Gabriela Lesyk, Paul Jurasz · Frontiers in Cardiovascular Medicine · 41
PDF
Role of von Willebrand factor in tumour cell‐induced platelet aggregation: differential regulation by NO and prostacyclin
2001 · Paul Jurasz, Michael W Stewart, et al. · British Journal of Pharmacology · 41
PDF
Pharmacological characteristics of solid‐phase von Willebrand factor in human platelets
2001 · Anna Radomski, Michael W Stewart, et al. · British Journal of Pharmacology · 37
Works count: 74
Citation count: 3,330
H-index: 30
I10-index: 44
Year
Topic
Type